By Michael Tomberlin
Southern Research has had great success in a number of areas, but none more than cancer treatment.
It remains a point of emphasis.
“We have seven FDA-approved drugs, two that will hopefully be approved soon and more in the pipeline,” said Rebecca Boohaker, assistant fellow in drug discovery at Southern Research. “Right now we’re working on a first-in-class therapy for pancreatic cancer and we’re also working towards developing therapies for immune oncology, which uses your immune system to fight the cancer.”
Please visit Alabama News Center for the Full Article
